CCK receptor

GPCR & G Protein

VEGFR EGFR IGF-1R c-Met c-Kit Tie-2 HER2 PDGFR c-RET Trk receptor TAM receptors (Tyro-3,Axl,and Mertk) CSF-1R Ephrin receptor ACK DDR ROS1 Pyk2 Tyro3 Axl Mertk Fer kinase RON Insulin Receptor

Isoform-selective Products

CCKB

All (4)
CCK receptor Inhibitor (1)
CCK receptor Antagonist (1)
CCK receptor Agonist (1)
CCK receptor Modulator (1)
New CCK receptor Products

Cat.No.	Product Name	Information	Product Use Citations	Product Validations
S2032	Rebamipide	Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [¹²⁵I]BH-CCK-8S with IC50 of 37.7 μM.	Signal Transduct Target Ther, 2021, 6(1):148 University of Alberta, 2014, Yahya Muhammad Fiteih
S9690	Caerulein (FI-6934)	Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.	J Adv Res, 2025, S2090-1232(25)00225-5 J Gastroenterol, 2025, 10.1007/s00535-025-02323-y
E7316	Cholecystokinin Octapeptide, desulfated	Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.
S6939	Nastorazepide	Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S2032	Rebamipide	Rebamipide (OPC-12759,Proamipide) is a cholecystokinin type 1 (CCK1) receptor inhibitor for inhibiting [¹²⁵I]BH-CCK-8S with IC50 of 37.7 μM.	Signal Transduct Target Ther, 2021, 6(1):148 University of Alberta, 2014, Yahya Muhammad Fiteih
S6939	Nastorazepide	Nastorazepide (Z-360), a cholecystokinin-2/gastrin receptor (CCK2/gastrin receptor) antagonist, combines with gemcitabine prolonged survival and reduces gemcitabine-induced vascular endothelial growth factor (VEGF) expression in a pancreatic carcinoma orthotopic xenograft mouse.
S9690	Caerulein (FI-6934)	Caerulein (Ceruletide, Cerulein, FI-6934), a cholecystokinin (CCK) receptor agonist, is a safe and effective cholecystokinetic agent and small bowel and exocrine pancreatic stimulant. Caerulein (FI-6934) can be used to induce animal models of acute pancreatitis.	J Adv Res, 2025, S2090-1232(25)00225-5 J Gastroenterol, 2025, 10.1007/s00535-025-02323-y
E7316	Cholecystokinin Octapeptide, desulfated	Cholecystokinin Octapeptide, desulfated, (CCK-8 (desulphated)) is a synthetic peptide lacking the sulfate group on its tyrosine residue, reducing its activity at CCK-A receptors while allowing selective binding to CCK-B receptors. It is used in research to study central and gastric effects mediated by CCK-B receptors, independent of digestive enzyme stimulation.